COVID-19 VACCINATION AMONG PEOPLE WITH DRUG ADDICTIONS: A CROSS-SECTIONAL STUDY
Background: The challenges of the coronavirus infection (COVID-19) pandemic dictate the need to ensure equal access to treatment and prevention services. This has become especially relevant in the context of widespread campaigns for vaccination of the population. Meanwhile, significant issues arise in the coverage of immunoprophylaxis for vulnerable social groups and in particular those who use psychoactive substances (PS). The uptake of and attitudes to COVID-19 vaccines in people with drug addictions remain uncertain.
The aim of the study is to assess the coverage of COVID-19 vaccination and its determinants among people with drug addictions.
Materials and methods: a cross-sectional study was conducted among 427 individuals with drug addictions by means of paper and electronic questionnaires. Socio-demographic characteristics, history of COVID-19, attitudes towards the pandemic, sources of information on preventive and therapeutic measures were recorded. Comparisons were made between two groups of respondents with different COVID-19 vaccination status. Descriptive statistical procedures included the calculation of the median and interquartile range, as well as proportions. The comparison was made using the Mann-Whitney test, contingency tables and the chi-square test. With logistic regression, the quantitative values of the abovementioned characteristics (odds ratio – OR- with 95% confidence interval) were determined for the probability of receiving COVID-19 vaccines.
Results: The proportion of those who reported receiving at least one dose of the vaccine was 61.4%. Persons who did not receive COVID-19 vaccines (n=165) were more likely to have lower level of education (χ2=17.17; p=0.004) and problems with employment (χ2=6.45; p=0.01), as well as to report lower monthly income (χ2=22.48; p<0.001). They less often indicated severe consequences and mortal cases due to COVID-19 among family members (χ2complications=12.93; p=0.002; χ2mortal=10.31; p=0.006). Only a fifth of all the respondents adequately assessed the high risks of contracting COVID-19 when using PS. Regression analysis revealed the following factors that increase the likelihood of receiving COVID-19 vaccines: annual GP visits (at least once a year) − OR = 2.06 (1.27; 3.35), receiving information about vaccines from physicians − OR = 2, 23 (1.24; 4.03), trust in medical specialists − OR=1.9 (1.15; 3.16).
Conclusions: insufficient access to reliable information about COVID-19 treatment and prevention among people with drug addictions, as well as their underestimation of the risks of the infection, dictates the need for educational interventions among this population group.
Mariya Prilutskaya1, https://orcid.org/0000-0002-9099-316X
Almas Kussainov2, https://orcid.org/ 0000-0003-1003-1735
Gulzhan Altybaeva3, https://orcid.org/0000-0001-9258-4928
Gulfayruz Tukinova1,
1 Pavlodar Branch of NCJSC «Semey Medical University», Pavlodar c., Republic of Kazakhstan;
2 Astana Medical University, Nur-Sultan c., Republic of Kazakhstan;
3 NCJSC «Semey Medical University», Semey c., Republic of Kazakhstan.
1. Брюн Е.А., Мелихов М.Г., Кошкина Е.А., и др. О наркологической ситуации в государствах-членах Организации договора о коллективной безопасности // Наркология. 2021. Т.20, № 1. C. 14–25.
2. Институт Центрально-Азиатского Регионально-го Экономического Сотрудничества. Анализ отношения общества к вакцинации от COVID-19 в отдельных странах. Аналитический отчет. г. Урумчи, 2021. 106 c.
3. Калиева А.А., Молдагалиев Т.М., Нурдыбаев А.К., Негай Н.А. Подростковая суицидальная активность и интернет-технологии: опыт анализа на региональном уровне // Наука и Здравоохранение. 2020. 1 (Т.22). С.88-97. doi:10.34689/SH.2020.22.1.010
4. Обзорно-аналитический портал Strategy2050.kz. Казахстанцев на 253 тысячи стало больше - 17.11.2021. https://strategy2050.kz/ru/news/kazakhstantsev-na-253-tysyachi-stalo-bolshe/ (дата обращения: 17.03.2022).
5. Республиканский научно-практический центр психического здоровья. Служба охраны психического здоровья. Статистический сборник, 2019-2020 гг. Алматы, 2021. 1–92 с.
6. Ситуация с коронавирусом официально. https://www.coronavirus2020.kz/ru/skol-ko-kazahstancev-vakcinirovalis-ot-covid-19_a3912368 (дата обращения: 17.03.2022).
7. Aceijas C., Hickman M., Donoghoe M.C., Burrows D., Stuikyte R. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia // Addiction. 2007. N102(8). P. 1244–1250.
8. Alshurman B.A., Khan A.F., Mac C., Majeed M., Butt Z.A. What demographic, social, and contextual factors influence the intention to use COVID-19 vaccines: a scoping review. // Int J Environ Res Public Health. 2021. N18(17). P. e9342. doi:10.3390/ijerph18179342
9. Altice F.L., Azbel L., Stone J., Brooks-Pollock E., Smyrnov P., Dvoriak S. et al. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia // Lancet. 2016. N388(10050). P. 1228–1248.
10. Arcadepani F.B., De Macedo M.A.C.F., Tardelli V.S., Martins S.S., Fidalgo T.M. COVID‐19 vaccination among socially vulnerable people who use drugs // Addiction. 2021. N116(9). P. 2590–2591.
11. Betsch C., Schmid P., Heinemeier D., Korn L., Holtmann C., Böhm R. Beyond confidence: Development of a measure assessing the 5C psychological antecedents of vaccination // PLOS ONE. 2018. N13(12). P. e0208601. doi: 10.1371/journal.pone.0208601.
12. Carey T.S., Crotty K.A., Morrissey J.P., Jonas D.E., Thaker S. et al. Future research needs for evaluating the integration of mental health and substance abuse treatment with primary care // Journal of Psychiatric Practice. 2013. N19(5). P. 345–359. doi: 10.1097/01.pra.0000435034.37685.ce.
13. Coronavirus [Электронный ресурс]. URL: https://www.who.int/health-topics/coronavirus#tab=tab_1 (дата обращения: 07.03.2022).
14. Every-Palmer S., Koning A., Smith L., Cunningham R. et al. Structural discrimination in the COVID-19 vaccination programme for people with mental health and addiction issues: now is the time to be equally well // New Zealand Medical Journal. 2022. N135(1550). P. 133–139.
15. Gerretsen P., Kim J., Caravaggio F., Quilty L., Sanches M., Wells S., Brown E.E., Agic B., Pollock B.G., Graff-Guerrero A. Individual determinants of COVID-19 vaccine hesitancy // PLOS ONE. 2021. N16(11). P. e0258462. doi: 10.1371/journal.pone.0258462
16. Iversen J., Peacock A., Price O., Byrne J., Dunlop A., Maher L. COVID-19 vaccination among people who inject drugs: Leaving no one behind // Drug and Alcohol Review. 2021. N40(4). P. 517–520.
17. Izekenova А.К., Bukharbayeva А.Е., Zhussupov B.S., Alekesheva L.Z., Erdenova М.А., Iskakova B.А., Myrkassymova А.K., Izekenova А.К., Karibayev К.B., Mergenova G.А. Assessing the trust of the population of Kazakhstan in sources of information during the pandemic COVID-19 // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 2, pp. 15-23. doi 10.34689/SH.2022.24.2.002
18. Masson C.L., McCuistian C., Straus E., Elahi S., et al. COVID-19 vaccine trust among clients in a sample of California residential substance use treatment programs // Drug and alcohol dependence. 2021. N225. P. e108812 doi: 10.1016/j.drugalcdep.2021.108812.
19. Mellis A.M., Kelly B.C., Potenza M.N., Hulsey J.N. Trust in a COVID-19 vaccine among people with substance use disorders // Drug and Alcohol Dependence. 2021. N220. P. e108519. doi: 10.1016/j.drugalcdep.2021.108519.
20. Mravcik V., Zabransky T., Talu A., Jasaitis E., Gafarova N., Musabekova Z., Baymirova L., Makhsutov M., Ganiev F. Mortality of registered drug users in Central Asia // International Journal of Drug Policy. 2014. N25(6). P. 1215–1220. doi: 10.1016/j.drugpo.2014.03.007.
21. Musa S., Skrijelj V., Kulo A., Habersaat K.B., Smjecanin M., Primorac E., Becirovic D, Jackson C. Identifying barriers and drivers to vaccination: A qualitative interview study with health workers in the Federation of Bosnia and Herzegovina // Vaccine. 2020. N38(8). P. 1906–1914. doi: 10.1016/j.vaccine.2020.01.025.
22. Padwa H., Teruya C., Tran E., Lovinger K., Antonini V.P., Overholt C., Urada D. The Implementation of Integrated Behavioral Health Protocols In Primary Care Settings in Project Care // Journal of Substance Abuse Treatment. 2016. N62. P. 74–83. doi: 10.1016/j.jsat.2015.10.002.
23. Rosenkranz M., Kerimi N., Takenova M., Impinen A., Mamyrov M., Degkwitz P., Zurhold H., Martens M.S. Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan // Harm reduction journal. 2016. N13(3). https://doi.org/10.1186/s12954-016-0093-2
24. Shen S., Dubey V. Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents // Canadian Family Physician. 2019. N65(3). P. 175.
25. Smyth B., Fan J., Hser Y.I. Life expectancy and productivity loss among narcotics addicts thirty-three years after index treatment // Journal of addictive diseases. 2006. N25(4). P. 37–47. doi: 10.1300/J069v25n04_04.
26. Tabacchi G., Tabacchi G., Costantino C., Napoli G., Marchese V. et al The Esculapio Working Group. Determinants of European parents’ decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis // Human Vaccines and Immunotherapeutics. 2016. N12(7). P. 1909–1923. doi: 10.1080/21645515.2016.1151990.
27. Tatar M., Shoorekchali J.M., Faraji M.R., Wilson F.A. International COVID-19 vaccine inequality amid the pandemic: Perpetuating a global crisis? // J Glob Health. 2021. N11. P. e03086. doi:10.7189/jogh.11.03086
28. Trujols J., Cadafalch J., Alvarado P.J., Duran-Sindreu S. Prioritizing COVID-19 vaccination for people with addictive disorders // Adicciones. 2021. N33(3). P. 285. doi: 10.20882/adicciones.1686.
29. Wang Q.Q., Kaelber D.C., Xu R., Volkow N.D. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States // Molecular Psychiatry. 2020. N26(1). P. 30–39. doi: 10.1038/s41380-020-00880-7.
30. White B., Dore G.J., Lloyd A., Rawlinson W., Maher L. Ongoing susceptibility to hepatitis B virus infection among people who inject drugs in Sydney // Australian and New Zealand Journal of Public Health. 2012. N36(4). P. 351–356. doi:10.1111/j.1753-6405.2012.00881.x
31. Zabransky T., Mravcik V., Talu A., Jasaitis E. Post-Soviet Central Asia: a summary of the drug situation // The International journal on drug policy. 2014. N25(6). P. 1186–1194.
32. Zolezzi M., Paravattil B., El-Gaili T. Using motivational interviewing techniques to inform decision-making for COVID-19 vaccination // International Journal of Clinical Pharmacy. 2021. N43(6). P. 1728-1734. doi: 10.1007/s11096-021-01334-y.
References: [1-6]:
1. Bryun E.A., Melikhov M.G., Koshkina E.A. et al. O narkologicheskoi situatsii v gosudarstvakh-chlenakh Organizatsii dogovora o kollektivnoi bezopasnosti [On the drug situation in the member states of the Collective Security Treaty Organization]. Narkologiya [Narcology]. 2021, 20, iss.1., pp. 14–25. [in Russian]
2. Institut Tsentral'no-Aziatskogo Regional'nogo Ekonomicheskogo Sotrudnichestva. Analiz otnosheniya obshchestva k vaktsinatsii ot COVID-19 v otdel'nykh stranakh Analiticheskii otchet. [Institute of Central Asian Regional Economic Cooperation. Analysis of public attitudes towards vaccination against COVID-19 in selected countries Analytical report]. Urumchi, 2021. 106 p. [in Russian]
3. Kaliyeva A.A., Moldagaliev T.M., Nurdybayev A.K., Negay N.A. Teenage suicidal activity and Internet technologies: regional analysis experience. Nauka i Zdravookhranenie [Science & Healthcare]. 2020, (Vol.22) 1, pp. 88-97. doi:10.34689/SH.2020.22.1.010 [in Russian]
4. Obzorno-analiticheskii portal Strategy 2050.kz. Kazakhstantsev na 253 tysyachi stalo bol'she - 17.11.2021. [Kazakhstanis increased by 253 thousand – 11.17.2021 Review and analytical portal Strategy2050.kz] Available: https://strategy2050.kz/ru/news/kazakhstantsev-na-253-tysyachi-stalo-bolshe/ (accessed: 17.03.2022). [in Russian]
5. Respublikanskii nauchno-prakticheskii tsentr psikhicheskogo zdorov'ya [Republican Scientific and Practical Center for Mental Health]. Sluzhba okhrany psikhicheskogo zdorov'ya. Statisticheskii sbornik, 2019-2020 gg. Almaty, [Mental health service. Statistical compendium, 2019-2020 Almaty]. 2021. pp.92 [in Russian]
6. Situatsiya s koronavirusom ofitsial'no [Coronavirus situation officially]. https://www.coronavirus2020.kz/ru/skol-ko-kazahstancev-vakcinirovalis-ot-covid-19_a3912368 (accessed: 17.03.2022). [in Russian]
Количество просмотров: 238
Категория статей:
Актуальная тема COVID-19
Библиографическая ссылка
Prilutskaya M., Kussainov A., Altybaeva G., Tukinova G. COVID-19 vaccination among people with drug addictions: a cross-sectional study // Nauka i Zdravookhranenie [Science & Healthcare]. 2022, (Vol.24) 5, pp. 28-35. doi 10.34689/SH.2022.24.5.004Похожие публикации:
CONSEQUENCES OF THE CORONAVIRUS INFECTION: THE POST-COVID SYNDROME AND MENTAL MANIFESTATIONS. LITERATURE REVIEW
EFFICACY OF THE ANTIVIRAL DRUG ENISAMY IODIDE IN SEVERE ADULT ACUTE RESPIRATORY INFECTIONS IN THE COVID-19 ERA
КЛИНИЧЕСКИЕ И СОЦИАЛЬНО-ДЕМОГРАФИЧЕСКИЕ ХАРАКТЕРИСТИКИ ПАЦИЕНТОВ С ПСИХИЧЕСКИМИ И ПОВЕДЕНЧЕСКИМИ РАССТРОЙСТВАМИ В ПОСТКОВИДНОМ ПЕРИОДЕ
ИММУНОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ У ДЕТЕЙ С МУЛЬТИСИСТЕМНЫМ ВОСПАЛИТЕЛЬНЫМ СИНДРОМОМ, АССОЦИИРОВАННЫМ С SARS-COV-2
КЛИНИЧЕСКАЯ КАРТИНА COVID-19 У ВЗРОСЛЫХ ПАЦИЕНТОВ ТУРКЕСТАНСКОЙ ОБЛАСТИ В ЗАВИСИМОСТИ ОТ СОПУТСТВУЮЩИХ ЗАБОЛЕВАНИЙ